A retropharyngeal abscess is a serious infection, usually starts in the lymph nodes, characterised by collection of pus at the back of the throat. Retropharyngeal abscess typically occurs in children under the age of eight, sometimes it can also affect adults. The symptoms of retropharyngeal abscess include difficulty or noisy breathing, difficulty and pain while swallowing, drooling, severe cough, severe throat pain, neck stiffness or swelling, muscle spasms in the neck among others. Retropharyngeal abscess is generally preceded by upper respiratory infections mostly a middle ear or sinus infection.
This report contains market size and forecasts of Retropharyngeal Abscess Treatment in Global, including the following market information:
Global Retropharyngeal Abscess Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Retropharyngeal Abscess Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Retropharyngeal Abscess Treatment include Pfizer, Sanofi, Novartis, Johnson & Johnson, GlaxoSmithKline, Merck, AstraZeneca, Mylan and Teva pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Retropharyngeal Abscess Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Retropharyngeal Abscess Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Retropharyngeal Abscess Treatment Market Segment Percentages, by Type, 2021 (%)
Antibiotics
Pain Killers
Surgical Drainage
Others
Global Retropharyngeal Abscess Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Retropharyngeal Abscess Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Retropharyngeal Abscess Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Retropharyngeal Abscess Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Retropharyngeal Abscess Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Retropharyngeal Abscess Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Sanofi
Novartis
Johnson & Johnson
GlaxoSmithKline
Merck
AstraZeneca
Mylan
Teva pharmaceutical